Plasma fibroblast growth factor 23 is associated with poor outcome and unsuccessful uptitration of guideline-recommended pharmacotherapy in patients with worsening heart failure

J. M. Jozine Ter Maaten; A. A. Voors; M. Metra; P. Van Der Harst; K. Dickstein; F. Zannad; J. G. Cleland; H. L. Hillege; K. Damman; M. H. De Borst

Plasma fibroblast growth factor 23 is associated with poor outcome and unsuccessful uptitration of guideline-recommended pharmacotherapy in patients with worsening heart failure

J. M. Jozine Ter Maaten, A. A. Voors, M. Metra, P. Van Der Harst, K. Dickstein, F. Zannad, J. G. Cleland, H. L. Hillege, K. Damman, M. H. De Borst

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Article number	674
Pages (from-to)	161-161
Number of pages	1
Journal	European Journal of Heart Failure
Volume	18
Publication status	Published - May-2016

Access to Document

https://insights.ovid.com/european-heart-failure/ejhf/2016/05/001/plasma-fibroblast-growth-factor-23-associated-poor/491/00127070

Handle.net

Persistent link

Cite this

Ter Maaten, J. M. J., Voors, A. A., Metra, M., Van Der Harst, P., Dickstein, K., Zannad, F., Cleland, J. G., Hillege, H. L., Damman, K., & De Borst, M. H. (2016). Plasma fibroblast growth factor 23 is associated with poor outcome and unsuccessful uptitration of guideline-recommended pharmacotherapy in patients with worsening heart failure. European Journal of Heart Failure, 18, 161-161. Article 674. https://insights.ovid.com/european-heart-failure/ejhf/2016/05/001/plasma-fibroblast-growth-factor-23-associated-poor/491/00127070

@article{14ae0b77d7414ae2a2e02b7a48616693,

title = "Plasma fibroblast growth factor 23 is associated with poor outcome and unsuccessful uptitration of guideline-recommended pharmacotherapy in patients with worsening heart failure",

author = "{Ter Maaten}, {J. M. Jozine} and Voors, {A. A.} and M. Metra and {Van Der Harst}, P. and K. Dickstein and F. Zannad and Cleland, {J. G.} and Hillege, {H. L.} and K. Damman and {De Borst}, {M. H.}",

year = "2016",

month = may,

language = "English",

volume = "18",

pages = "161--161",

journal = "European Journal of Heart Failure",

issn = "1388-9842",

publisher = "Wiley",

}

Ter Maaten, JMJ , Voors, AA, Metra, M, Van Der Harst, P, Dickstein, K, Zannad, F, Cleland, JG, Hillege, HL , Damman, K & De Borst, MH 2016, 'Plasma fibroblast growth factor 23 is associated with poor outcome and unsuccessful uptitration of guideline-recommended pharmacotherapy in patients with worsening heart failure', European Journal of Heart Failure, vol. 18, 674, pp. 161-161. <https://insights.ovid.com/european-heart-failure/ejhf/2016/05/001/plasma-fibroblast-growth-factor-23-associated-poor/491/00127070>

Plasma fibroblast growth factor 23 is associated with poor outcome and unsuccessful uptitration of guideline-recommended pharmacotherapy in patients with worsening heart failure. / Ter Maaten, J. M. Jozine ; Voors, A. A.; Metra, M. et al.
In: European Journal of Heart Failure, Vol. 18, 674, 05.2016, p. 161-161.

Research output: Contribution to journal › Meeting Abstract › Academic

TY - JOUR

T1 - Plasma fibroblast growth factor 23 is associated with poor outcome and unsuccessful uptitration of guideline-recommended pharmacotherapy in patients with worsening heart failure

AU - Ter Maaten, J. M. Jozine

AU - Voors, A. A.

AU - Metra, M.

AU - Van Der Harst, P.

AU - Dickstein, K.

AU - Zannad, F.

AU - Cleland, J. G.

AU - Hillege, H. L.

AU - Damman, K.

AU - De Borst, M. H.

PY - 2016/5

Y1 - 2016/5

M3 - Meeting Abstract

SN - 1388-9842

VL - 18

SP - 161

EP - 161

JO - European Journal of Heart Failure

JF - European Journal of Heart Failure

M1 - 674

ER -